Literature DB >> 15188456

Centrosome amplification and aneuploidy in bone marrow failure patients.

William G Kearns1, Hiroki Yamaguchi, Neal S Young, Johnson M Liu.   

Abstract

Patients with bone marrow failure are at risk for development of hematopoietic progenitor clones with abnormal numbers of chromosomes (aneuploidy) and leukemia. Numerical centrosome abnormalities or mutations in genes associated with the mitotic spindle checkpoint (BUB1 and MAD2) are two important mechanisms that can induce abnormal mitosis resulting in aneuploid daughter cells. To assess the role of these mechanisms, we used fluorescence in situ hybridization techniques to determine aneuploidy and centrosome copy number and PCR-SSCP to identify gene mutations of BUB1 and MAD2 in marrow cells of 25 patients. No mutations were found in BUB1 or MAD2 genes. However, we found that cells with more than two centrosomes exhibited aneuploidy for three or more chromosomes. We conclude that centrosome amplification may be associated with the development of a clonal population of potentially preleukemic aneuploid cells. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15188456     DOI: 10.1002/gcc.20043

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

2.  Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.

Authors:  Varvara Trachana; Karel H M van Wely; Astrid Alonso Guerrero; Agnes Fütterer; Carlos Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-13       Impact factor: 11.205

3.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.

Authors:  Stefan Stein; Marion G Ott; Stephan Schultze-Strasser; Anna Jauch; Barbara Burwinkel; Andrea Kinner; Manfred Schmidt; Alwin Krämer; Joachim Schwäble; Hanno Glimm; Ulrike Koehl; Carolin Preiss; Claudia Ball; Hans Martin; Gudrun Göhring; Kerstin Schwarzwaelder; Wolf-Karsten Hofmann; Kadin Karakaya; Sandrine Tchatchou; Rongxi Yang; Petra Reinecke; Klaus Kühlcke; Brigitte Schlegelberger; Adrian J Thrasher; Dieter Hoelzer; Reinhard Seger; Christof von Kalle; Manuel Grez
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

Review 4.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

5.  Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group.

Authors:  Christoph E Heilig; Harald Löffler; Ulrich Mahlknecht; Johannes W G Janssen; Anthony D Ho; Anna Jauch; Alwin Krämer
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.